Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

448

HTML

2258

Figures (1-4)

125

Tables (1-3)

108

Sum=2939

May 15, 2003 (publication date) through Apr 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. May 15, 2003; 9(5): 930-935
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.930

Figure 1 Positive expression of bcl-2 in the renal stroma cell, while negative in tubular epithelium in the cisplatin group (SP, × 400).

Figure 2 Positive expression of bc1-2 in renal tubular epithelium in medium dose arsenic group (SP, × 400).

Figure 3 PCNA expression in renal collecting tubular epithelium and stroma cells in the cisplatin group (SP, × 400).

Figure 4 PCNA expression in renal cortex tubular cells in medium dose in arsenic group epithelium (SP, × 400).

Citation: Wang SS, Zhang T, Wang XL, Hong L, Qi QH. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World J Gastroenterol 2003; 9(5): 930-935
URL: https://www.wjgnet.com/1007-9327/full/v9/i5/930.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i5.930